Dr. Dimitry Michael Palceski, DO

Dr. Palceski practices at Reflections Dermatology and Center for Skin Care in Winter Park, Florida.

Dr. Palceski's NPI, 1265407290, was assigned on February 22, 2006. Dr. Palceski graduated from Chicago College of Osteopathic Medicine at Midwestern University in 2001. Dr. Palceski holds Florida license OS9674.

Dr. Palceski's primary practice is Reflections Dermatology and Center for Skin Care, at 440 W Morse Blvd, Winter Park, FL 32789 in Orange County. The practice phone is (407) 895-8818.

Dr. Palceski's primary practice is Reflections Dermatology and Center for Skin Care in Winter Park, Florida. The medical group on file is Reflections Dermatology & Center for Skin Care. Dmand AI also links Dr. Palceski to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Palceski practices. Vendor and product names are available with a free account.

Procedural dermatology is Dr. Palceski's primary specialty in the NPI Registry, under taxonomy code 207NS0135X. Dr. Palceski is board certified in dermatology by the AOA Board of Dermatology. Dr. Palceski is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, psoriasis and rash among the conditions Dr. Palceski treats.

CMS data shows 32,224 Medicare services from Dr. Palceski across 19 procedure codes in 2024, for 308 Medicare patients. Medicare paid $115,936 for them. Every service was in an office.

CMS counts 308 Medicare patients who saw Dr. Palceski in 2024. The largest group is 65 to 74, with 180 patients. 75% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Palceski's median patient age at 43, with 60% women.

In 2024, Dr. Palceski wrote 364 Medicare Part D claims for 171 patients. 86% of them were for generic drugs. CMS names the drug for 233 of them, across 9 drugs with 11 or more claims each, at $101,894 in total drug cost. In 2023, CMS named 255 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Palceski for performance year 2024, reported individually. Dr. Palceski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 122 procedures of melanoma (skin cancer) excision by Dr. Palceski, more than 94% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Palceski in 2019. Dr. Palceski's most frequent co-authors are Kevin Tate Belasco, DO, James Del Rosso, DO and Amanda D. Friedrichs, MD.

CMS Open Payments shows 1,966 general payments to Dr. Palceski from 58 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Galderma Laboratories, L.P. paid the most, $41,524. It also lists 1 research payment totaling $2,500 in 2016.

Dmand AI lists 3 awards for Dr. Palceski, most recently CMS Stage 1 2012 in 2012.

Dr. Palceski graduated from Chicago College of Osteopathic Medicine at Midwestern University in 2001. Dr. Palceski is a member of AAD, AOA and ASDS.

Dr. Palceski is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.